Clinical Trial

Zadek Osteotomy for Treatment of Haglund's Syndrome

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 5, 2025 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
Haglund's syndrome is an abnormality of the bone and soft tissues in the foot. An enlargement of the bony section of the heel (where the Achilles tendon is inserted) triggers this condition. * symptom includes insertional Achilles tendinopathy (IAT), The patient with HS often has a red, irritated, painful heel. And they often complain the enlargement of the posterior heel, which make it more difficult to footwear or sport * Zadek described the Zadek Osteotomy option for the treatment of Haglund's syndrome This operation can change the calcaneus' anatomical length and elevate the distal insertion point of the Achilles tendon \- It is a prospective case series study that will be done in Orthopedics and Traumatology department of Sohag university hospitals on patients suffering from Haglund's syndrome and treated by Zadek osteotomy * This study aims to evaluate short term clinical, radiological and functional outcomes of Zadek osteotomy for treatment of Haglund's syndrome
Trial Details
NCT Number NCT07157319
Lead Sponsor Sohag University
Conditions Haglund's Disease
Enrollment 30 participants
Start Date 2025-04-01
Primary Completion 2025-10 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-09-05